AXIM Biotechnologies (AXIM) Stock Statistics & Valuation Metrics

AXIM Biotechnologies has a market cap or net worth of $1.16M. The enterprise value is $9.24M.

AXIM Biotechnologies has 340,456,630 shares outstanding. The number of shares has decreased by -2.65% in one year.

AXIM Biotechnologies’s return on equity (ROE) is 0.09 and return on invested capital (ROIC) is 41.24%.

The current PE Ratio of AXIM Biotechnologies is ―. AXIM Biotechnologies’s PEG ratio is 0.05.

In the last 12 months, AXIM Biotechnologies had revenue of 0.00 and earned -1.04M in profits. Earnings per share was >-0.01.

In the last 12 months, operating cash flow was 706.61K and capital expenditures 5.00, giving a free cash flow of 706.61K billion.

AXIM Biotechnologies pays an annual dividend of ―, resulting in a dividend yield of ―

AXIM Biotechnologies upcoming earnings date is Mar 19, 2018, TBA (Confirmed).

AXIM Biotechnologies as a current ratio of <0.01, with Debt / Equity ratio of -69.46%

In the past 12 months, AXIM Biotechnologies has paid 0.00 in taxes.

AXIM Biotechnologies EV to EBITDA ratio is -12.80, with an EV/FCF ratio of -16.65.

AXIM Biotechnologies has $10.40K in cash and marketable securities with $7.78M in debt, giving a net cash position of -$7.77M billion.

Gross margin is -8.71%, with operating margin of 0.00%, and net profit margin of 0.00%.

The average price target for AXIM Biotechnologies is ―, which is 11.43% higher than the current price. The consensus rating is ―